e-learning
resources
Berlin 2001
Sunday 23.09.2001
Etiology of LRTI
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Resistance of
Streptococcus pneumoniae
to penicillin, azitromycin, ciprofloxacyn and ceftriaxon
V. I. Kotevska, A. Kaftandzieva, N. Panovski, M. Petrovska (Skopje, Macedonia)
Source:
Annual Congress 2001 - Etiology of LRTI
Session:
Etiology of LRTI
Session type:
Thematic Poster Session
Number:
936
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. I. Kotevska, A. Kaftandzieva, N. Panovski, M. Petrovska (Skopje, Macedonia). Resistance of
Streptococcus pneumoniae
to penicillin, azitromycin, ciprofloxacyn and ceftriaxon. Eur Respir J 2001; 16: Suppl. 31, 936
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Resistance to penicillin among the Streptococcus pneumoniae in Turkey
Source: Eur Respir J 2001; 18: 436
Year: 2001
Emergence of penicillin resistant
Streptococcus pneumoniae
in Pakistan
Source: Eur Respir J 2005; 26: Suppl. 49, 639s
Year: 2005
Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae
Source: Eur Respir J 2006; 27: 1020-1025
Year: 2006
CusS-cusR mediate carbapenem-resistant Klebsiella pneumoniae resistant to tigecycline.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections
Source: Eur Respir J 2002; 20: 3S-8S
Year: 2002
Quinolones consume and
streptococcus pneumoniae
antibiotic resistance
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Increasing global resistance to penicillin, macrolides and other antimicrobials among isolates of
Streptococcus pneumoniae
: susceptibility data from three years of the PROTEKT surveillance study
Source: Eur Respir J 2003; 22: Suppl. 45, 486s
Year: 2003
Therapeutic efficacy of macrolides, minocycline and tosufloxacin against macrolide-resistant
Mycoplasma pneumoniae
pneumonia in pediatric patients
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Treatment challenges in methicillin resistant
Staphylococcus aureus
infections
Source: Annual Congress 2006 - Methicillin resistant
Staphylococcus aureus
(MRSA): a real hospital-based pathogen?
Year: 2006
Mechanisms of acquisition of resistance in
Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant
Staphylococcus aureus
(MRSA): a real hospital-based pathogen?
Year: 2006
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis
Source: Eur Respir J 2007; 29: 1127-1137
Year: 2007
Azithromycin treatment failure in macrolide-resistant Mycoplasma pneumoniae pneumonia
Source: Eur Respir J 2010; 36: 969-971
Year: 2010
What is MRSA?
Source: Eur Respir J 2009; 34: 1190-1196
Year: 2009
Levofloxacin resistance among streptococcus pneumoniae isolates in a chronic disease hospital
Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Year: 2010
Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial
Source: Eur Respir J 2004; 23: 921-926
Year: 2004
Vancomycin MICs for respiratory isolates of community-associated MRSA and hospital-associated MRSA
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007
Evolution of tetracycline resistant S. aureus in hypoxia
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021
Activity of N-acetylcysteine in combination with colistin against a collection of colistin resistant Acinetobacter baumannii clinical isolates
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017
Streptococcus pneumoniae
antibiotic resistance from 1986 to 2004
Source: Eur Respir J 2005; 26: Suppl. 49, 640s
Year: 2005
Clinical outcomes of patients with hospital-acquired pneumonia due to community-associated methicillin resistant
staphylococcus aureus
(CA-MRSA)
Source: Eur Respir J 2007; 30: Suppl. 51, 407s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept